These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6636687)

  • 1. [Disorders of lipoprotein metabolism as a risk factor in atherosclerosis in patients with glomerulonephritis].
    Nikulina GG; Petrun' NM; Mel'man NIa; Zel'dich IM; Serbina IE
    Vrach Delo; 1983 Aug; (8):53-6. PubMed ID: 6636687
    [No Abstract]   [Full Text] [Related]  

  • 2. [Characteristics of lipoprotein metabolism impairments in nephrotic syndrome].
    Titov VN; Tvorogova MG; Levitova EN; Krylova EA
    Vopr Med Khim; 1983; 29(2):17-23. PubMed ID: 6858031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein peroxidation in adult psoriatic patients.
    Offidani AM; Ferretti G; Taus M; Simonetti O; Dousset N; Valdiguie P; Curatola G; Bossi G
    Acta Derm Venereol Suppl (Stockh); 1994; 186():38-40. PubMed ID: 8073834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipoprotein (a) as a risk factor in the development of atherosclerosis].
    Liakishev AA; Pokrovskiĭ SN; Susekov AV
    Kardiologiia; 1991 Feb; 31(2):71-5. PubMed ID: 1828281
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progress in the study of lipoprotein metabolism and atherosclerosis: role of blood lipoproteins and pathogenesis of atherosclerosis].
    Kawamura M; Naito C
    Nihon Rinsho; 1988 Mar; 46(3):621-8. PubMed ID: 3404688
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum lipid and lipoprotein profile in children with malabsorption: an approach to the recognition of atherosclerosis risk factors.
    Szczepański Z; Malecka-Torbus A; Obuchowicz A; Swietochowska I; Zaba R; Wróbel-Lasok B
    Acta Paediatr Acad Sci Hung; 1981; 22(4):309-12. PubMed ID: 6952747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular diseases and clinical laboratory examination. (5). Atherosclerosis and abnormal metabolism of lipids].
    Hirabaru K; Yamasaki S
    Rinsho Byori; 1983 Oct; 31(10):1078-82. PubMed ID: 6674578
    [No Abstract]   [Full Text] [Related]  

  • 8. [Arteriosclerosis indices of lipid and lipoprotein metabolism].
    Reuter W; Herrmann W; Voigt H; Köhler H; Schütz C; Hanf S; Lindhofer HG; Kuklinski B
    Z Arztl Fortbild (Jena); 1984; 78(6):239-41. PubMed ID: 6730538
    [No Abstract]   [Full Text] [Related]  

  • 9. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
    Skålén K; Gustafsson M; Rydberg EK; Hultén LM; Wiklund O; Innerarity TL; Borén J
    Nature; 2002 Jun; 417(6890):750-4. PubMed ID: 12066187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipoprotein (a): a strong risk factor in atherosclerosis].
    Maranhão RC; Pileggi F
    Arq Bras Cardiol; 1990 May; 54(5):337-42. PubMed ID: 2149632
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lipoprotein (a)--a risk factor for atherosclerosis].
    Meiner V; Leitersdorf E
    Harefuah; 1992 Aug; 123(3-4):115-8. PubMed ID: 1387627
    [No Abstract]   [Full Text] [Related]  

  • 12. ["Atherosclerosis-index" (LDL/HDL): risk indicator in lipid metabolism disorders].
    Mertz DP
    Med Klin; 1980 Feb; 75(4):159-61. PubMed ID: 7374617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipids and proteins of lipoproteins in human atherosclerosis.
    Avogaro P; Bittolo-Bon G; Cazzolato G; Belussi F; Pontoglio E
    Przegl Lek; 1983; 40(10):713-8. PubMed ID: 6665207
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipoprotein metabolism and cardiovascular disease.
    Packard CJ; Shepherd J
    Biochem Soc Trans; 1987 Jun; 15(3):341-3. PubMed ID: 2957255
    [No Abstract]   [Full Text] [Related]  

  • 15. [Characteristics of the indicators of the lipoprotein spectrum of blood and the main risk factors of the development of arteriosclerosis among university students in different regions of the USSR].
    Olfer'ev AM; Shamarin VM; Petrosian KIu; Koval' SN; Konobeevskaia IN; Aripov BS; Zadoia NA; Nazarenko IL; Kanskaia NV; Kulikov SM
    Sov Med; 1991; (9):46-9. PubMed ID: 1839195
    [No Abstract]   [Full Text] [Related]  

  • 16. [The importance of cholesterol in high-density lipoproteins in determining risk for atherosclerosis].
    Brücknerová O
    Vnitr Lek; 1982 Jan; 28(1):15-22. PubMed ID: 7058632
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of calcium, magnesium, lead, or cadmium on lipoprotein metabolism and atherosclerosis in the pigeon.
    Revis NW; Major TC; Horton CY
    J Environ Pathol Toxicol; 1980 Sep; 4(2-3):293-303. PubMed ID: 7462906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipoprotein (a)--a further risk factor in arteriosclerosis?].
    Ritter MM; Richter WO
    Fortschr Med; 1990 Oct; 108(29):547-9, 554. PubMed ID: 2147016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factors, atherosclerosis and thromboembolism in the nephrotic syndrome].
    Previato G; Loschiavo C; Tessitore N; Chiaramonte S; Oldrizzi L; Lupo A; Valvo E; Maschio G; Saporiti E
    Minerva Nefrol; 1981; 28(3):421-30. PubMed ID: 7036020
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interaction of multiply-modified (desialated) low-density lipoproteins, isolated from the blood of patients with atherosclerosis,with cellular receptors].
    Tertov VV; Sobenin IA; Nazarova VL; Gil'dieva BS; Via DP; Orekhov AP
    Biull Eksp Biol Med; 1994 Jan; 117(1):53-5. PubMed ID: 8193331
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.